• 1. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

4-Bromo-3-ethoxyaniline Hydrochloride (CAS No. 125756-95-8): A Comprehensive Overview

4-Bromo-3-ethoxyaniline hydrochloride (CAS No. 125756-95-8) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This aromatic amine derivative, characterized by its bromine and ethoxy functional groups, serves as a versatile intermediate in synthetic chemistry. Its molecular formula is C₈H₁₀BrNO·HCl, and it typically appears as a white to off-white crystalline powder. Researchers value this compound for its role in constructing complex molecules, particularly in drug discovery and material science.

The unique structure of 4-bromo-3-ethoxyaniline HCl makes it invaluable for cross-coupling reactions, a hot topic in modern organic synthesis. With the growing demand for Pd-catalyzed reactions and Suzuki-Miyaura couplings in pharmaceutical manufacturing, this compound has become increasingly relevant. Its bromo substituent acts as an excellent leaving group, facilitating nucleophilic substitution reactions, while the ethoxy group provides electron-donating properties that influence the compound's reactivity.

In the pharmaceutical industry, 4-bromo-3-ethoxyaniline hydrochloride serves as a key building block for various active pharmaceutical ingredients (APIs). Recent studies highlight its potential in developing central nervous system (CNS) drugs, aligning with current research trends in neuroscience and psychiatric medications. The compound's ability to form hydrogen bonds through its amine group makes it particularly useful in designing molecules that interact with biological targets.

From a synthetic chemistry perspective, CAS 125756-95-8 demonstrates excellent solubility in polar organic solvents like dimethyl sulfoxide (DMSO) and methanol, but limited solubility in water. This property makes it ideal for various organic transformations while allowing for easy purification processes. The hydrochloride salt form enhances the compound's stability, addressing a common challenge in handling aromatic amines.

The thermal stability of 4-bromo-3-ethoxy aniline HCl has been extensively studied, with decomposition typically occurring above 200°C. This characteristic is crucial for researchers performing high-temperature reactions or microwave-assisted synthesis - two techniques gaining popularity in modern laboratories. The compound's stability profile also makes it suitable for long-term storage, an important consideration for chemical inventory management.

Analytical chemists frequently employ high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy to characterize 4-bromo-3-ethoxyaniline hydrochloride. These techniques verify the compound's purity and structure, ensuring it meets the stringent requirements of pharmaceutical applications. Recent advancements in analytical instrumentation have made quality control processes more efficient for such specialized intermediates.

Environmental considerations surrounding brominated compounds have led to increased research into the green chemistry applications of 4-bromo-3-ethoxyaniline HCl. Scientists are exploring catalytic systems that minimize waste generation during its utilization, aligning with the pharmaceutical industry's push toward sustainable synthesis. This focus on environmental impact reflects current concerns about chemical sustainability in industrial processes.

The global market for fine chemical intermediates like 4-bromo-3-ethoxyaniline hydrochloride has shown steady growth, driven by expanding pharmaceutical R&D budgets. Suppliers typically offer this compound in various packaging options, from gram-scale quantities for research laboratories to kilogram-scale for industrial applications. Proper handling requires standard laboratory precautions, including the use of personal protective equipment (PPE) and adequate ventilation.

Recent patent literature reveals innovative applications of CAS 125756-95-8 in developing fluorescence probes and organic electronic materials. These emerging applications capitalize on the compound's conjugated aromatic system and ability to participate in electron transfer processes. Such developments position this chemical intermediate at the intersection of multiple cutting-edge research fields.

Quality specifications for 4-bromo-3-ethoxyaniline hydrochloride typically require ≥98% purity, with strict limits on residual solvents and heavy metals. Reputable suppliers provide comprehensive certificates of analysis (CoA) and material safety data sheets (MSDS), addressing the pharmaceutical industry's stringent documentation requirements. These quality assurance measures support the compound's use in Good Manufacturing Practice (GMP) environments.

As research continues into structure-activity relationships and molecular design, the importance of specialized intermediates like 4-bromo-3-ethoxyaniline HCl will likely grow. Its balanced combination of reactivity and stability makes it particularly valuable for medicinal chemistry programs targeting various disease areas. The compound's versatility ensures its continued relevance in both academic and industrial settings.

Storage recommendations for 4-bromo-3-ethoxyaniline hydrochloride typically suggest keeping the material in a cool, dry place, protected from light and moisture. These conditions help maintain the compound's stability over extended periods. Researchers should also consider inert atmosphere storage for particularly sensitive applications, though the hydrochloride form generally offers good air stability.

The synthesis of 4-bromo-3-ethoxyaniline typically involves electrophilic aromatic bromination of 3-ethoxyaniline, followed by salt formation with hydrochloric acid. Process chemists continue to optimize these synthetic routes to improve yields and reduce byproducts, reflecting the industry's focus on process efficiency. Recent publications have explored alternative bromination reagents that offer improved selectivity and environmental profiles.

In conclusion, 4-bromo-3-ethoxyaniline hydrochloride (CAS No. 125756-95-8) represents a valuable tool for synthetic chemists, particularly in pharmaceutical research. Its unique structural features and versatile reactivity profile ensure its continued importance in drug discovery and material science. As chemical research evolves toward more complex molecular architectures, intermediates like this will remain essential building blocks for innovation across multiple scientific disciplines.

• 232275-47-7(4-Bromo-3,5-dimethoxyaniline)
• 1375068-73-7(4-Bromo-5-propoxybenzene-1,2-diamine)
• 1041853-14-8(4-Bromo-3-(2-methoxyethoxy)aniline)
• 191602-43-4(3-bromo-4-(propan-2-yloxy)aniline)
• 67853-38-7(2-Bromo-3-methoxyaniline Hydrochloride)
• 846023-33-4(4-bromo-3-ethoxyaniline hydrochloride)
• 19056-40-7(4-Bromo-3-methoxyaniline)
• 80523-34-8(3-Bromo-4-methoxyaniline hydrochloride)
• 52765-17-0(Benzenamine, 3,5-dibromo-4-ethoxy-)
• 101251-12-1(3-bromo-4-ethoxyBenzenamine)